RPG Life to launch kidney drug in US
RPG Life Sciences Ltd (RPGLS) is planning to enter the US generic drug market with its offering - cyclosporin - a drug used on kidney transplantat patients. A release issued by the RPG group here
RPG Life Sciences Ltd (RPGLS) is planning to enter the US generic drug market with its offering - cyclosporin - a drug used on kidney transplantat patients. A release issued by the RPG group here